ウェビナー動画：Sanofi社、高分子医薬品研究向けプラットフォームとしてGenedata Biologicsを活用

本動画では、同社の高分子研究組織においてグローバルデータガバナンス戦略を実現した方法を紹介しています。FAIR原則に則ったデータの統合・連携・統一化により、自動化やAI/MLを活用したアプローチを効果的に展開し、データ駆動型の意思決定を促進しています。

Learn how Sanofi has established a global data governance strategy to promote data best practices within Sanofi’s Large Molecules Research (LMR) Organization.

Katja Kroll, Digital Biologics Platform Site Lead at Sanofi, explains how by using Genedata Biologics as their data backbone, Sanofi has established FAIR data usage and integrated, connected, and unified diverse data streams in a single, high-quality resource. This investment in data quality has paid major dividends and has allowed Sanofi to effectively deploy automation, machine learning, and artificial intelligence-based approaches for efficient drug development and data-driven decision making.

Who should watch? 

• Data Scientists struggling with insufficient data quality
• Biopharma R&D managers wondering how to implement AI/ML effectively in drug development
• Quality assurance staff trying to handle the increasing complexity of advanced technologies and multimodal data
• Lab Scientists seeking to increase throughput and minimize error
• IT managers tasked with supporting maximum business value from data assets